BlackRock Institutional Trust’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$4.23M Buy
260,639
+89,900
+53% +$1.36M ﹤0.01% 2789
2016
Q3
$2.3M Buy
170,739
+104,808
+159% +$2.15M ﹤0.01% 2996
2016
Q2
$1.61M Buy
65,931
+8,265
+14% +$279K ﹤0.01% 3122
2016
Q1
$1.99M Buy
+57,666
New +$1.52M ﹤0.01% 3047

Other funds holding EDIT

BlackRock Institutional Trust's EDIT Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Editas Medicine (EDIT) stake by 53% in Q4 2016, buying an estimated $1.36M and bringing the position to 260,639 shares worth $4.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2789.

BlackRock Institutional Trust first reported a position in EDIT in Q1 2016 and has held it in 4 quarters since. 84 funds tracked by Wall St. Rank hold EDIT as of Q4 2016.

  • BlackRock Institutional Trust held 260,639 shares of Editas Medicine worth $4.23M as of Q4 2016.
  • BlackRock Institutional Trust bought 89,900 Editas Medicine shares in Q4 2016, an estimated $1.36M.
  • Editas Medicine made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2789 holding.
  • BlackRock Institutional Trust first reported a position in Editas Medicine in Q1 2016 and has held it in 4 quarters since.
  • 84 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.